Industry News
All Warner News
Top stories summarized by our editors
Top stories summarized by our editors

Senate bill would require reporting of cyber breaches

7/22/2021

A bill introduced by Sen. Mark Warner, D-Va., would protect companies from liability in the event of a data breach while requiring the reporting of such incidents. "We shouldn't be relying on voluntary reporting to protect our critical infrastructure," Warner said.

Exec sees a smooth Warner-Discovery merger approval

6/21/2021

AT&T anticipates a smooth approval process for the merger between WarnerMedia and Discovery, executive Pascal Desroches told investors, but still expects final clearance to take roughly a year. Discovery head David Zaslav is emphasizing learning and trust as he prepares to lead the united company.

Exec sees a smooth Warner-Discovery merger approval

6/16/2021

AT&T anticipates a smooth approval process for the merger between WarnerMedia and Discovery, executive Pascal Desroches told investors, but still expects final clearance to take roughly a year. Discovery head David Zaslav is emphasizing learning and trust as he prepares to lead the united company.

Exec sees a smooth Warner-Discovery merger approval

6/16/2021

AT&T anticipates a smooth approval process for the merger between WarnerMedia and Discovery, executive Pascal Desroches told investors, but still expects final clearance to take roughly a year. Discovery head David Zaslav is emphasizing learning and trust as he prepares to lead the united company.

How automated software validation will affect pharma

6/8/2021

Machine learning, artificial intelligence, neural networks and predictive analytics will have a huge impact on the software validation life cycle in the pharmaceutical, biopharmaceutical and medical device industries, writes Kathleen Warner, vice president of consulting services at RCM Technologies, in the first of a three-part series. "By applying the concept of continuous life cycle management for software development, advantages such as the ability to address risk (critical, high, medium, etc.) during each stage of the development process are feasible," Warner writes.

How automated software validation will affect pharma

6/3/2021

Machine learning, artificial intelligence, neural networks and predictive analytics will have a huge impact on the software validation life cycle in the pharmaceutical, biopharmaceutical and medical device industries, writes Kathleen Warner, vice president of consulting services at RCM Technologies, in the first of a three-part series. "By applying the concept of continuous life cycle management for software development, advantages such as the ability to address risk (critical, high, medium, etc.) during each stage of the development process are feasible," Warner writes.